2022
DOI: 10.1016/j.jddst.2022.103117
|View full text |Cite
|
Sign up to set email alerts
|

Designing and development of omega-3 fatty acid based self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel with enhanced biopharmaceutical attributes for management of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 47 publications
0
12
0
Order By: Relevance
“…The diffusion exponent ( n ) value was found as 1.38, which indicated the drug permeation followed the supercase II transport. 35 …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The diffusion exponent ( n ) value was found as 1.38, which indicated the drug permeation followed the supercase II transport. 35 …”
Section: Resultsmentioning
confidence: 99%
“…Ltd., Maharashtra, India) following the previous procedure with slight modification. 35 The dissolution apparatus type-II (paddle) was used for this study. The dissolution vessels were filled with 900 mL of releasing medium made with PBS containing 0.25% w/v sodium lauryl sulphate (pH 6.8, 37 °C).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…SNEDDSs are inherently associated with a burst release and face the challenge of dose dumping in case of a poorly developed system [ 14 ]. It is difficult to deliver SNEDDSs while controlling their release, thus making this highly effective technology a poor option for the sustained or controlled release for treating GIT issues [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…S-SNEDDS are formulated by the liquid loading techniques. They may have the combined advantages of solid dosage form and L-SNEDDS (i.e improved solubility and bioavailability) (8) .…”
Section: Introductionmentioning
confidence: 99%